sc-3115
|
Santa Cruz Biotechnology
|
GSK-3beta substrate (negative control)
|
|
WB, IF, ELISA
|
|
sc-221766
|
Santa Cruz Biotechnology
|
IRTK Activator, Negative Control [CAS 6172-50-5]
|
|
|
|
sc-221776
|
Santa Cruz Biotechnology
|
JAK3 Inhibitor, Negative Control [CAS 153437-07-1]
|
|
|
|
sc-221781
|
Santa Cruz Biotechnology
|
JNK Inhibitor II, negative control [CAS 54642-23-8]
|
|
|
|
sc-204815
|
Santa Cruz Biotechnology
|
Necrostatin-1, inactive control [CAS 64419-92-7]
|
|
|
|
sc-3061
|
Santa Cruz Biotechnology
|
NFKappaB control
|
|
|
|
sc-471135
|
Santa Cruz Biotechnology
|
OmniMMP™ fluorogenic control [CAS 140430-55-3]
|
|
|
|
sc-3100
|
Santa Cruz Biotechnology
|
PKC Epsilon Translocation negative control
|
|
|
|
sc-204201
|
Santa Cruz Biotechnology
|
PKR Inhibitor, Negative Control [CAS 852547-30-9]
|
|
|
|
sc-396537
|
Santa Cruz Biotechnology
|
Q-VE-OPh (Negative Control)
|
|
|
|
sc-222260
|
Santa Cruz Biotechnology
|
Ro106-9920, Control
|
|
|
|
sc-204281
|
Santa Cruz Biotechnology
|
SIRT2 Inhibitor, Inactive Control [CAS 304896-21-7]
|
|
|
|